Hoth Therapeutics, Inc.
NASDAQ: RKTO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Robbie Knie
- Employees
- 6
- Headquarters
- Hoboken, United States
- Market cap
- $21.3M
- Website
- http://www.hoththerapeutics.com
Loading RKTO…
Loading profile data…Frequently asked questions about RKTO
What does Hoth Therapeutics, Inc. (RKTO) do?
Hoth Therapeutics, Inc. specializes in developing next-generation therapeutic approaches for a range of dermatological ailments. Its active development pipeline includes investigational treatments targeting conditions such as atopic dermatitis (more commonly known as eczema), persistent wounds, psoriasis, asthma, and acne. A key offering from th...
Where does RKTO trade?
Hoth Therapeutics, Inc. (RKTO) trades on the NASDAQ Global Market.
What sector is RKTO in?
Hoth Therapeutics, Inc. (RKTO) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Hoth Therapeutics, Inc.?
Robbie Knie is the chief executive officer of Hoth Therapeutics, Inc. (RKTO).
Where is Hoth Therapeutics, Inc. headquartered?
Hoth Therapeutics, Inc. is headquartered in United States.
Does RKTO pay a dividend?
Hoth Therapeutics, Inc. (RKTO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.